Recombinant Rana pipiens S-arrestin

Shipped with Ice Packs
In Stock

Description

Introduction to Recombinant Rana pipiens S-Arrestin

Recombinant Rana pipiens S-arrestin is a genetically engineered protein derived from the American bullfrog (Rana pipiens), a model organism widely used in visual system studies. S-arrestin (also called arrestin-1 or retinal S-antigen) is a key regulator of phototransduction, binding to activated and phosphorylated rhodopsin to terminate light signaling and initiate receptor internalization . Its recombinant form is produced via heterologous expression systems, enabling precise structural and functional studies in vitro.

Molecular Architecture

S-arrestin consists of two β-sheet domains connected by a flexible hinge region, with a C-terminal tail critical for receptor binding . In Rana pipiens, the protein shares conserved features with mammalian S-arrestin, including phosphorylation-dependent binding to rhodopsin’s intracellular loops and transmembrane helix 7 (TM7) .

FeatureDescriptionSource
Molecular Weight~48 kDa (rod arrestin isoform)
Binding PartnersPhosphorylated rhodopsin, clathrin, and AP-2 complexes
Phosphorylation SitesThr-340 and Ser-343 in rhodopsin (critical for S-arrestin interaction)

Mechanism of Action

  1. Signal Termination: Binds to light-activated, GRK1-phosphorylated rhodopsin, blocking G-protein (transducin) coupling .

  2. Internalization: Facilitates rhodopsin clustering in clathrin-coated pits via interactions with β2-adaptin and clathrin heavy chain .

  3. Signaling Redirection: May recruit MAPK pathways, though this is less characterized in Rana pipiens compared to β-arrestins .

Recombinant Expression Systems

Recombinant Rana pipiens S-arrestin is typically produced in:

Host SystemPurification MethodTagsPurityApplications
YeastProtein G affinity chromatographyHis, Myc, Strep>90%ELISA, Western blotting
HEK-293 CellsSDS-PAGE/Coomassie stainingN/A>80%Structural studies
BaculovirusUnspecifiedN/AN/AFunctional assays (e.g., pull-down)

Storage: -20°C to -80°C; repeated freeze-thaw cycles discouraged .

Research Applications

  • Phototransduction Assays: Studying rhodopsin desensitization and internalization .

  • Structural Biology: Crystallization for X-ray diffraction (e.g., PDB ID: 4ZWJ for rhodopsin-S-arrestin complex) .

  • Antibody Validation: Used as an antigen in monoclonal antibody development (e.g., clone S128) .

Role in Phototransduction Regulation

  1. Rhodopsin Binding Kinetics: S-arrestin binds activated rhodopsin with higher affinity than β-arrestins bind non-visual GPCRs, as shown in single-molecule microscopy studies .

  2. Ciliary Localization: In frog rod outer segments, S-arrestin modulates the balance between rhodopsin activation and quenching, preventing light-induced damage .

Comparative Studies

SpeciesS-Arrestin FunctionKey Findings
Rana pipiensRhodopsin inactivationRequires coexpression with GRK1
Homo sapiensCone photoreceptor signalingPreferentially binds cone arrestin (arrestin-4)
Mus musculusRod photoreceptor signalingMutations linked to Retinitis Pigmentosa

Challenges and Future Directions

  • Species-Specific Variations: Rana pipiens S-arrestin shows higher specificity for rhodopsin compared to non-visual arrestins, limiting cross-reactivity in assays .

  • Therapeutic Potential: While β-arrestins are explored for GPCR-targeted therapies, Rana pipiens S-arrestin research remains focused on basic phototransduction mechanisms .

Q&A

What is S-arrestin from Rana pipiens and what is its role in photoreceptor function?

S-arrestin (also known as Retinal S-antigen or Rod photoreceptor arrestin) from Rana pipiens (Northern leopard frog) is a member of the arrestin protein family that plays a critical role in the visual signal transduction pathway. This protein participates in the inactivation of rhodopsin and other heptahelical receptors by binding to their activated and phosphorylated states. This binding blocks the ability of these receptors to activate G proteins, thus terminating the signaling cascade .

The protein consists of 396 amino acids and functions primarily in rod photoreceptor cells, where it regulates light sensitivity and adaptation. Unlike mammalian arrestins, frog arrestins (including those from R. pipiens) contain a uniquely acidic C-terminal sequence that may confer specific functional properties in amphibian visual systems .

How does Rana pipiens S-arrestin compare to arrestins from other species?

Comparative analysis of Rana pipiens S-arrestin with arrestins from other species reveals:

  • The protein shares similarity with other vertebrate arrestins but has distinctive features specific to amphibians

  • Compared to mammalian arrestins, Rana arrestins contain a uniquely acidic C-terminal sequence that may influence their binding kinetics or regulatory properties

  • Three regions of the protein are well conserved across all phylogenetic groups, suggesting their critical role in arrestin function, particularly in binding to heptahelical receptors

  • Studies have identified four retinal arrestins from Rana species (two from rod photoreceptors and two from cone photoreceptors), showing specialization within the amphibian visual system

What expression systems are recommended for producing recombinant Rana pipiens S-arrestin?

The choice of expression system significantly impacts protein quality and functionality. Based on the available data:

Expression SystemAdvantagesConsiderationsTypical Yield
YeastPost-translational modifications, high yield, proper foldingLonger expression time, complex purificationVariable, >90% purity achievable
E. coliRapid expression, cost-effective, simpler protocolsMay lack proper folding, limited post-translational modificationsHigh yield, >95% purity possible
Mammalian (HEK-293)Native-like post-translational modificationsMore expensive, lower yieldModerate yield, >90% purity
Cell-free protein synthesisRapid production, avoids toxicity issuesLimited scale, higher costVariable

The commercial recombinant Rana pipiens S-arrestin described in the search results is expressed in yeast and purified to >90% purity with a His tag . For structural and functional studies requiring high purity and proper folding, yeast or mammalian expression systems are recommended over bacterial systems. The choice depends on the specific research application and required protein characteristics.

What purification strategies are most effective for recombinant Rana pipiens S-arrestin?

Effective purification of recombinant Rana pipiens S-arrestin typically follows these methodological steps:

  • Affinity chromatography: Using His-tag affinity purification as the primary step, leveraging the incorporated His-tag in the recombinant protein

  • Ion exchange chromatography: As a secondary purification step, taking advantage of the protein's charge properties, particularly the acidic C-terminal region

  • Size exclusion chromatography: For final polishing and buffer exchange, ensuring high purity and removal of aggregates

For optimal results, consider these methodological recommendations:

  • Maintain reducing conditions throughout purification to prevent disulfide bond formation

  • Include protease inhibitors to prevent degradation

  • Optimize elution conditions to maintain protein stability and activity

  • Verify protein integrity through SDS-PAGE and Western blotting with specific antibodies

  • Confirm functionality through binding assays with rhodopsin or other appropriate targets

What methods can be used to assess the binding activity of Rana pipiens S-arrestin to photoreceptors?

Several methodological approaches can be employed to evaluate S-arrestin binding activity:

  • Split luciferase complementation assays: This approach involves fusing NanoLuc subunits to arrestin and the receptor, allowing real-time monitoring of protein-protein interactions when they come into proximity . This has been successfully applied to study arrestin recruitment to GPCRs.

  • BRET-based approaches: Bioluminescence Resonance Energy Transfer assays provide a reliable method for measuring protein-protein interactions in live cells and can be used to compare relative binding strengths of wild-type vs. mutant arrestins .

  • Direct vs. indirect assays: Both approaches have been validated for studying arrestin recruitment:

    • Direct assays detect the immediate interaction between arrestin and receptors

    • Indirect assays specifically detect interactions at the plasma membrane

  • Comparative potency analysis: When studying arrestin recruitment to different receptors, concentration-response experiments with reference agonists can provide quantitative measurements of binding affinity and kinetics .

How can researchers distinguish between non-specific binding and functional interactions when using recombinant S-arrestin?

Distinguishing specific from non-specific binding requires methodological controls:

  • Negative controls: Include non-phosphorylated receptors or receptors in inactive conformations that should not bind arrestin with high affinity

  • Competition assays: Perform binding studies in the presence of unlabeled arrestin to determine specific vs. non-specific interactions

  • Mutational analysis: Compare binding of wild-type S-arrestin with mutants lacking key binding interfaces. For example, mutations in the conserved domains identified across arrestin family members can serve as controls

  • Membrane localization controls: Higher baseline signals observed in some indirect assays may result from non-specific arrestin recruitment to the membrane . These can be controlled by using membrane markers or comparative analysis with known binding partners

  • Signal-to-baseline ratio evaluation: For accurate interpretation, calculate the signal-to-baseline ratio after stimulation with agonist compared to direct assay measurements

How do the conserved regions in Rana pipiens S-arrestin contribute to its binding specificity?

Comparative sequence analysis has identified three regions in arrestin proteins that are well conserved across all phylogenetic groups . These regions are hypothesized to function in the binding of arrestin to heptahelical receptors. For Rana pipiens S-arrestin, these conserved domains likely mediate:

  • Initial recognition of the activated, phosphorylated receptor state

  • Conformational changes that occur upon binding

  • Stabilization of the arrestin-receptor complex

The unique C-terminal sequence in Rana arrestins, characterized by its acidic nature, may provide additional binding specificity or regulatory functions not present in mammalian arrestins . This region could influence:

  • Binding kinetics (association/dissociation rates)

  • Specificity for different phosphorylation patterns

  • Interactions with other components of the signaling pathway

Research approaches to investigate these regions include:

  • Targeted mutagenesis of conserved residues

  • Chimeric proteins combining domains from different arrestin types

  • Truncation studies to assess the role of the C-terminal acidic region

What experimental considerations are important when using recombinant Rana pipiens S-arrestin for structural studies?

When preparing recombinant Rana pipiens S-arrestin for structural studies:

  • Protein purity requirements:

    • For crystallography or cryo-EM: >95% purity is typically required

    • For NMR studies: isotopic labeling may be necessary, requiring specialized expression systems

  • Stability considerations:

    • Buffer optimization to maintain native conformation

    • Assessment of thermal stability using differential scanning fluorimetry

    • Evaluation of long-term storage conditions (temperature, additives, freeze-thaw cycles)

  • Binding state selection:

    • Pre-bound to receptor fragments for studying complex structures

    • Free form for studying intrinsic conformational states

    • Use of phosphorylated peptides mimicking receptor C-termini

  • Sample preparation protocols:

    • Concentration methods that avoid protein aggregation

    • Detergent selection if studying membrane protein interactions

    • Tag removal considerations (if His-tag affects structure)

How can different assay systems for studying arrestin recruitment be compared and validated?

Research data shows that different assay systems can yield varying results when studying arrestin recruitment. For valid comparisons:

  • Concentration-response experiments: Perform these with reference agonists across different assay platforms. For example, studies comparing direct and indirect assays for arrestin recruitment to B2AR, GRPR, and SSTR2 showed similar potency values for most receptors (B2AR: 145±10 nM vs. 161±12 nM; SSTR2: 61±8 nM vs. 80±15 nM), with significant differences only for GRPR (583±65 nM vs. 344±63 nM) .

  • Assay comparison controls: When establishing a new assay system, validate it against established methods. For example, recruitment efficacies of different β-arrestin-2 mutants to B2AR showed no significant differences between direct assay and classical BRET-based approaches .

  • Consideration of assay limitations:

    • The indirect assay only detects receptor-arrestin interactions at the plasma membrane, not during internalization

    • Some receptors may behave differently during the internalization process

    • Higher baseline observed in some indirect assays may result from non-specific arrestin recruitment to the membrane

  • Signal normalization: Set the maximum response (Emax) to 100% for each tested GPCR individually since absolute light emission cannot be compared among different GPCRs .

What are the key differences between rod and cone arrestins in Rana pipiens?

Research has identified distinct arrestins from rod and cone photoreceptors in Rana pipiens . Key differences include:

  • Sequence variation: While sharing core functional domains, rod and cone arrestins have specialized sequences that reflect their distinct roles in different photoreceptor types

  • Expression patterns: Using PCR on reverse-transcribed mRNA from single photoreceptor cells, researchers demonstrated that specific arrestin variants are exclusively expressed in either rod or cone cells

  • Functional specialization: The differences likely reflect adaptations to the distinct signaling properties and light sensitivity ranges of rod versus cone photoreceptors

  • Evolutionary conservation: Comparison of rod and cone arrestins across species can reveal the evolutionary pressures that have shaped visual systems in different ecological niches

What evolutionary insights can be gained from studying amphibian arrestins compared to mammalian counterparts?

Comparative analysis of amphibian arrestins provides several evolutionary insights:

  • Conserved functional domains: The three well-conserved regions identified across all arrestin sequences suggest fundamental mechanisms that have been preserved throughout vertebrate evolution

  • Species-specific adaptations: The uniquely acidic C-terminal sequence in Rana arrestins represents a specialized adaptation that differentiates amphibian visual systems from those of mammals

  • Photoreceptor specialization: The presence of distinct rod and cone arrestins in frogs reflects the evolutionary importance of specialized visual signaling pathways in different light conditions

  • Functional conservation across diverse species: Despite sequence divergence, the core functions of arrestins in regulating GPCR signaling are maintained across vertebrates, highlighting the fundamental importance of this regulatory mechanism

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.